// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

GENETIC, CELLULAR, AND CONNECTOMIC CHARACTERIZATION OF THE ADULT HUMAN BRAIN REGIONS COMMONLY PLAGUED BY GLIOMA

Ayan Mandal - Society for Neuro-Oncology (SNO) , 2020

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Low-grade gliomas

N/A

AI-BASED PROGNOSTIC IMAGING BIOMARKERS FOR PRECISION NEUROONCOLOGY AND THE RESPOND CONSORTIUM

Christos Davatzikos - Society for Neuro-Oncology (SNO) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Glioblastoma

N/A

PROGNOSTIC SIGNIFICANCE OF EPIGENETIC SUBTYPES AND CpGs ASSOCIATED WITH PROGRESSION TO G-CIMP LOW IN THE EORTC RANDOMIZED PHASE III INTERGROUP CATNON

C Mircea S Tesileanu - Society for Neuro-Oncology (SNO) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Gliomas

N/A

GENOMIC LANDSCAPE OF IDH-MUTANT PRIMARY GLIOBLASTOMAS SHOWS DISTINCT CLINICAL AND MOLECULAR FEATURES AND THAT CDKN2A SHOULD BE SUPPLEMENTED WITH MGMTp AND G-CIMP FOR PRECISE PROGNOSTICATION

Queenie Hoi-Wing Wong - Society for Neuro-Oncology (SNO) , 2020

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Glioblastoma

TP53

SURGEONS TRIAL OF PROPHYLAXIS FOR EPILEPSY IN SEIZURE NAÏVE PATIENTS WITH MENINGIOMA: A RANDOMIZED CONTROLLED TRIAL (STOP ‘EM)

Michael Jenkinson - Society for Neuro-Oncology (SNO) , 2020

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Meningiomas

Levetiracetam

THE ROLE OF IFITMs IN MAINTAINING GLIOMA STEM CELLS

Erisa Nita - Society for Neuro-Oncology (SNO) , 2020

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Glioblastoma

IFN-lambda

A CANCER STEM CELL-SELECTIVE APOPTOSIS-INDUCING SMALL MOLECULE FOR THE TREATMENT OF GBM

Stephen Skirboll - Society for Neuro-Oncology (SNO) , 2020

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

EFFICACY OF SOLUBLE PANOBINOSTAT (MTX110) IN PRECLINICAL MODELS OF ADULT GLIOBLASTOMA

David Ashley - Society for Neuro-Oncology (SNO) , 2020

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Glioblastoma

Panobinostat

Tube surgery in scarry eyes!

F. Ahmed - European Association for Vision and Eye Research (EVER) , 2017

Therapeutic Area

Disease

Drug/Treatment

Ophthalmology (OP)

Glaucoma

N/A

Absence of nuclear Programmed cell death 4 as an indicator of poor prognosis in uveal melanoma patients

I. Ahmed - European Association for Vision and Eye Research (EVER) , 2017

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Uveal melanoma

N/A

Changes in the X‐ray diffraction pattern of porcine lens before and after simulated accommodation

S. Al-Atawi - European Association for Vision and Eye Research (EVER) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The SRPK1 inhibitor SPHINX31 prevents increased retinal permeability in a rodent model of diabetes

C. Allen - European Association for Vision and Eye Research (EVER) , 2017

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Diabetes

Streptozotocin

The efficacy of heating devices to warm the lids

R. Almutairi - European Association for Vision and Eye Research (EVER) , 2017

Therapeutic Area

Disease

Drug/Treatment

Ophthalmology (OP)

Blepharitis

N/A

Effects of plasma kallikrein inhibitors in an in vitro RPE oxidative stress model

M.L. Alonso-Alonso - European Association for Vision and Eye Research (EVER) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

benzalkonium chloride solution

Corneal clarity measurements in patients with myopia undergoing laser assisted in situ keratomileusis and laser assisted sub‐epithelial keratectomy

K. Alzahrani - European Association for Vision and Eye Research (EVER) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Corneal haze in juvenile and adult keratoconus patients after corneal cross‐linking

K. Alzahrani - European Association for Vision and Eye Research (EVER) , 2017

Therapeutic Area

Disease

Drug/Treatment

Ophthalmology (OP)

Keratoconus

N/A

Glaucoma Drainage Device (tube) surgery ‐ what I learned from my first 20 cases

N. Anand - European Association for Vision and Eye Research (EVER) , 2017

Therapeutic Area

Disease

Drug/Treatment

Ophthalmology (OP)

Glaucoma

N/A

Ab interno glaucoma surgery ‐ what I learned from my first 20 cases

L. Au - European Association for Vision and Eye Research (EVER) , 2017

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Glaucoma

N/A

Case series and literature review: Is there a role for antiviral prophylaxis in patients who have had herpetic encephalitis?

S. Balendra - European Association for Vision and Eye Research (EVER) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Measurement of oculomotor parameters and visual processing times without eye‐tracking

J.L. Barbur - European Association for Vision and Eye Research (EVER) , 2017

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved